Cognitive Impairment Cohort Study of the Elderly Population in SheMountain
Not yet recruiting
- Conditions
- Cognitive ImpairmentMild Cognitive ImpairmentDementiaNeurodegenerative DiseasesAlzheimer Disease
- First Posted Date
- 2022-12-29
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05667935
- Locations
- 🇨🇳
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
ENB Guided MWA Combined With VATS Versus Sequential Surgery for Synchronous Bilateral Multiple Primary Lung Nodules
Not Applicable
Recruiting
- Conditions
- Multiple Primary Lung Cancer
- Interventions
- Procedure: sequential surgeryProcedure: ENB guided MWA combined with VATS
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2023-01-10
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 172
- Registration Number
- NCT05662553
- Locations
- 🇨🇳
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
Not Applicable
Recruiting
- Conditions
- NK/T-cell Lymphoma
- Interventions
- Device: Positron Emission Tomography/Magnetic Resonance (PET/MR)
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05662540
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Glycation of apoA-I and Diabetic Atherogenesis
Active, not recruiting
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Other: overnight fasting
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05659043
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Radiomics in Pancreatic Cancer
Active, not recruiting
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05658679
Ruijin Neurobank of Alzheimer's Disease and Dementia
Recruiting
- Conditions
- Dementia
- Interventions
- Other: No intervention
- First Posted Date
- 2022-11-21
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT05623124
- Locations
- 🇨🇳
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
Phase 2
Recruiting
- Conditions
- Soft Tissue SarcomaAnlotinibHigh Risk of RecurrenceRadiotherapy
- Interventions
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 41
- Registration Number
- NCT05602415
- Locations
- 🇨🇳
Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
Recruiting
- Conditions
- Neurodegenerative DiseasesAlzheimer DiseaseDementiaCognitive ImpairmentNeurocognitive Disorders
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 3418
- Registration Number
- NCT05597410
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer
Phase 4
Not yet recruiting
- Conditions
- Non-muscle-invasive Bladder Cancer
- Interventions
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT05580354
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
Phase 2
Not yet recruiting
- Conditions
- Rectal CancerLocally Advanced
- Interventions
- First Posted Date
- 2022-10-12
- Last Posted Date
- 2022-10-12
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 55
- Registration Number
- NCT05576480
© Copyright 2025. All Rights Reserved by MedPath